Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsHow a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.
A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.
Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.
Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.
Symptomatic relief from nerve stimulation treatment may persist after stopping the treatment in most children with overactive bladder.
Unsweetened dairy may help protect enamel, but added sugar can erase the benefit. Breastfeeding and milk alternatives also have surprising age- and product-specific effects.
In primary care settings, recognizing the difference between seborrheic keratosis and melanoma can guide timely biopsy and reduce missed diagnoses.
1.
Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk
2.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
3.
Glioblastoma cells can 'unstick' from their neighbors to become more deadly
4.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
5.
In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.
1.
Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS
2.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
3.
Understanding Axitinib: What You Need To Know For Your Treatment Plan
4.
Targeting Oncology: Expanding Combinatorial Strategies by 2025
5.
Precision Oncology Advances: Neoantigen Therapies, TCR Strategies & Radiotherapy Innovations
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge